Generation bio to present at the jmp securities life sciences conference

Cambridge, mass., june 09, 2021 (globe newswire) -- generation bio co. (nasdaq: gbio), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that geoff mcdonough, m.d., president and chief executive officer, will present at the jmp securities life sciences conference on wednesday, june 16, at 11:30 a.m. et.
GBIO Ratings Summary
GBIO Quant Ranking